Project Grant R03AG089057
Award Date
9/27/24
Completion Date
8/31/26
Dollars Obligated
$624K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The federal Project Grant award R01AG089237, funded by the National Institute on Aging's Aging Research program (CFDA 93.866), aims to determine the effectiveness of a shared decision-making (SDM) toolkit in decreasing surveillance mammography use among breast cancer survivors aged 80 and older. The total award amount is $943,540.00 over the project period from Sep 15, 2024 to Aug 31, 2029. The award recipient is the Dana-Farber Cancer Institute, Inc. (DFCI), a non-profit hospital and cancer...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $388,750 to The Washington University to conduct research on the role of senescent cancer-associated fibroblasts (senCAFs) in breast cancer progression. The key objectives are to: 1) Determine the organ-specific effects of senCAFs on metastatic breast cancer progression; 2) Examine how senCAFs impact extracellular matrix dynamics and tumor cell migration; and 3) Assess the impact of senCAFs on...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a $811,443 cluster randomized trial to evaluate the impact of a shared decision-making (SDM) training program for breast surgeons and a patient decision aid for women aged 70+ with early-stage, low-risk breast cancer. The goal is to reduce the use of low-value treatments, such as mastectomy, sentinel lymph node biopsy, and radiation therapy after breast-conserving surgery, without...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. will support a $734,942 research project over 5 years from August 2025 to July 2030. The research aims to evaluate how biological aging metrics, such as epigenetic clocks and leukocyte composition, are associated with cardiovascular disease (CVD) and mortality risk in breast cancer survivors. The project will...
This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $349,561 to The Regents of the University of California, San Francisco to conduct the "Promoting Gynecologic Cancer Patients with Frailty to Achieve Functional Recovery Cohort Study (PROOF Cohort Study)". The study aims to 1) objectively assess physical frailty in patients aged 50 and older with advanced ovarian or uterine cancer, and quantify associations with perioperative...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,128,604.00 to The University of Texas MD Anderson Cancer Center to investigate the relationships between immunosenescence, brain aging biomarkers, and cognition across non-human primate species with differing lifespans. The project aims to elucidate the role of the immune system in longevity, neurodegeneration, and cognitive decline, which may inform the development of immuno-restorative...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $115,411.00 to evaluate dynamic changes in aging-related clinical decline among older survivors with early-stage non-small cell lung cancer. The award to Weill Medical College of Cornell University aims to identify multilevel determinants, including social determinants of health, associated with disparities in clinical decline trajectories. This longitudinal study of over 89,000 lung...
This Project Grant award of $674,227, provided by the National Institute on Aging (NIA) under CFDA 93.866 Aging Research, will fund a study to evaluate the impact of the 340B Drug Pricing Program on Medicare Part D medication utilization, health outcomes, and disparities. The primary objectives are to: 1) Assess the impact of 340B program growth on Medicare Part D medication volumes and characteristics, overall and among disadvantaged subgroups; 2) Evaluate the impact of 340B eligibility on...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $243,750 to the Sanford Burnham Prebys Medical Discovery Institute to conduct research on the impact of aging on the initiation and progression of pancreatic ductal adenocarcinoma (PDAC). The key objectives are to 1) examine how the aging stroma (tumor microenvironment) affects PDAC tumor growth and metastasis, and 2) investigate the influence of age on the intrinsic oncogenic potential of the...
This Project Grant awarded by the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), will investigate aspects of the Medicare Advantage (MA) program that pose problems for beneficiaries with serious illnesses, such as cancer. The $110,644 grant awarded to Vanderbilt University will have three aims: 1) describing the breadth and quality of skilled nursing facilities in MA plan networks, 2) examining the association between oncology network breadth and disenrollment...